Company news
Merit Medical Systems, Inc. (NASDAQ:MMSI) news
Merit Medical Systems, Inc. news releases on 6ix. Latest, Oct 6, 2026: Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026
Press releases & updates
Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026
October 6, 2026
Merit Medical to Participate in Upcoming Investors Conferences in September
September 4, 2026
Merit Medical Announces Global Operations Leadership Transition
August 19, 2026
Merit Medical to Participate in Upcoming Investors Conferences in August
August 5, 2026
Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance
July 30, 2026
Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026
July 2, 2026
Merit Medical Shareholders Elect Scott R. Ward to Board of Directors
May 18, 2026
Merit Medical to Participate in the Bank of America Healthcare Conference
May 8, 2026
Merit Medical Reports First Quarter 2026 Results and Updates Full-Year Guidance
April 30, 2026
Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026
April 1, 2026
Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio
March 31, 2026
Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain
March 23, 2026
Merit Medical Launches the Resilience Through-the-Scope Esophageal Stent
March 15, 2026
Merit Medical Reports Fourth Quarter and Full Year 2025 Results and Issues Fiscal Year 2026 Guidance
February 24, 2026
Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025
January 7, 2026
Merit Medical to Participate at the J.P. Morgan Healthcare Conference
December 22, 2025
Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis
November 12, 2025
Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
November 4, 2025
Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
November 2, 2025
Merit Medical Reports Third Quarter 2025 Results and Updates Full-Year Guidance
October 29, 2025
Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon Technology
October 14, 2025
Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025
October 2, 2025
Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology
September 30, 2025
Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis
September 11, 2025
First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry
August 17, 2025
Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology
August 6, 2025
Merit Medical Reports Second Quarter 2025 Results and Updates Full-Year Guidance
July 29, 2025
Martha Aronson to Step Down from CONMED Board of Directors Following Appointment as President and Chief Executive Officer of Merit Medical Systems, Inc.
July 7, 2025
Merit Medical Names Martha Aronson as New President and Chief Executive Officer
July 6, 2025
Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
July 2, 2025
Merit Medical Acquires Biolife Delaware, L.L.C.
May 19, 2025
Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
May 5, 2025
Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial
May 4, 2025
Merit Medical Reports First Quarter 2025 Results and Updates Full-Year Guidance
April 23, 2025
Merit Medical Launches the Ventrax™ Delivery System
April 8, 2025
Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025
April 6, 2025
Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)
March 24, 2025
Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership
March 17, 2025
First Patient Enrolled in Merit Medical’s PREEMIE Study
March 9, 2025
Merit Medical Reports Fourth Quarter and Full Year 2024 Results and Issues Fiscal Year 2025 Guidance
February 24, 2025
Merit Medical Announces Preliminary Unaudited Revenue for the Year Ended December 31, 2024 and Plans to Announce Fourth Quarter and Year End 2024 Results and Issue Fiscal Year 2025 Guidance on February 25, 2025
January 12, 2025
Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
December 19, 2024
Merit Medical Announces Resignation of President, Joseph Wright
December 15, 2024
Merit Medical’s WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft (AVG) Patients
November 24, 2024
Merit Medical Completes Acquisition of Lead Management Portfolio from Cook Medical
October 31, 2024
Merit Medical Reports Third Quarter 2024 Results and Raises Full-Year Guidance
October 29, 2024
Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
October 7, 2024
Merit Medical Signs Agreement to Purchase Lead Management Portfolio from Cook Medical
September 16, 2024
Merit Medical’s WRAPSODY WAVE Trial Demonstrates Superior Patency versus Standard of Care in AV Fistula Patients
September 15, 2024
Merit Medical to Present at the 2024 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress
September 10, 2024